CoChat

Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier

Open access
Tang, Benjamin C., Dawson, Michelle, Lai, Samuel K., Wang, Ying-Ying, Suk, Jung Soo, Yang, Ming, Zeitlin, Pamela, Boyle, Michael P., Fu, Jie, Hanes, Justin · 2009 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

Protective mucus coatings typically trap and rapidly remove foreign particles from the eyes, gastrointestinal tract, airways, nasopharynx, and female reproductive tract, thereby strongly limiting opportunities for controlled drug delivery at mucosal surfaces. No synthetic drug delivery system composed of biodegradable polymers has been shown to penetrate highly viscoelastic human mucus, such as non-ovulatory cervicovaginal mucus, at a significant rate. We prepared nanoparticles composed of a biodegradable diblock copolymer of poly(sebacic acid) and poly(ethylene glycol) (PSA-PEG), both of which are routinely used in humans. In fresh undiluted human cervicovaginal mucus (CVM), which has a bulk viscosity approximately 1,800-fold higher than water at low shear, PSA-PEG nanoparticles diffused at an average speed only 12-fold lower than the same particles in pure water. In contrast, similarly sized biodegradable nanoparticles composed of PSA or poly(lactic-co-glycolic acid) (PLGA) diffused at least 3,300-fold slower in CVM than in water. PSA-PEG particles also rapidly penetrated sputum expectorated from the lungs of patients with cystic fibrosis, a disease characterized by hyperviscoelastic mucus secretions. Rapid nanoparticle transport in mucus is made possible by the efficient partitioning of PEG to the particle surface during formulation. Biodegradable polymeric nanoparticles capable of overcoming human mucus barriers and providing sustained drug release open significant opportunities for improved drug and gene delivery at mucosal surfaces.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0905998106

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. RA Cone, Mucus. Mucosal Immunology, eds PL Ogra, ME Lamm, W Strober, JR McGhee, J Mestecky, J Bienenstock (Academic, 3 Ed, San Diego), pp. 43–64 (1999).

Cited by

  • PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

    Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523

    “Importantly, numerous methods for producing biodegradable NPs with sufficiently dense PEG coatings for rapid penetration through human CVM have been described [133, 136-138], providing an array of options for developing NP-based therapies for more efficacious vaginal drug delivery.”
    Self-citation
  • Biomedical applications of biodegradable polymers

    Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206

  • Nanoparticle PEGylation for Imaging and Therapy

    Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046

    “However, there are many other PEGylated polymers for making drug-containing NPs, including polylactic acid [79], poly(hexadecylcyanoacrylate) (PHDCA) [21], polycaprolactone [80], chitosan [81] and poly(sebacic acid) [82].”
    Background
  • Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

    Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623

    “This mucoinert coating has been translated to engineering biodegradable nanoparticles [8], nanoparticles capable of penetrating highly viscoelastic cystic fibrosis sputum [7], and biodegradable particles composed entirely of “generally regarded as safe” (GRAS) ingredients [10].”
    BackgroundSelf-citation
  • Nanoparticles in the clinic

    Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321

    “Interestingly, recent preclinical work has highlighted advantages of PEGylated particles beyond extended circulation, notably their diffusion in tissues(118) and their abilities to pass through tight biological barriers.(36,119) It is possible that clinically used PEGylated particles have benefitted from these effects.”
    Background

See all 453

Metadata

Authors
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J.
Affiliations
  • Johns Hopkins University (US)
  • Georgia Institute of Technology (US)
Venue
Proceedings of the National Academy of Sciences
Published
2009-11-17
Volume
106
Issue
46
Pages
19268-19273
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2071026997
Cited by
453
References
47
Citations by year
2026: 15 · 2025: 17 · 2024: 16 · 2023: 22 · 2022: 20 · 2021: 25 · 2020: 31 · 2019: 26 · 2018: 33 · 2017: 40 · 2016: 33 · 2015: 31 · 2014: 35 · 2013: 29 · 2012: 33
FWCI
18.18
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R21HL089816)
  • National Cancer Institute (R01CA140746)
  • National Center for Research Resources (UL1RR025005)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
mucus penetration, biodegradable polymer nanoparticles, cervicovaginal mucus, polyethylene glycol, poly(lactic-co-glycolic acid), mucus viscosity, nanoparticle diffusion, sputum, cystic fibrosis, mucosal drug delivery, sustained drug release
MeSH terms
Anhydrides, Cervix Mucus, Cystic Fibrosis, Drug Carriers, Female, Humans, Polyethylene Glycols, Sputum, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. https://app.cochat.ai/papers/10.1073/pnas.0905998106
The paper
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009). Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0905998106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.